MedPath

TO study efficacy of non cultured, non trypsinised epidermal cell transplantation(a type of skin grafting procedure) in stable(non progressive, resitant to medical treatment) vitiligo.

Phase 2
Conditions
Health Condition 1: L80- Vitiligo
Registration Number
CTRI/2020/11/028973
Lead Sponsor
Department of Dermatology Venerology and Leprosy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

12 years and above

stable vitiligo

Exclusion Criteria

1.Presence of koebnerâ??s phenomenon

2.Refusal to consent

3.Pregnancy or lactation

4.Patients with unrealistic expectations from treatment

5.Patients with a tendency for keloid formation

6.Active cutaneous infection

7.History suggestive of autoimmune disorders

8.Patient with any hematological or coagulation disorders or on anticoagulation therapy

Patients who are immunosuppressed

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Degree of RepigmentationTimepoint: 16 Week
Secondary Outcome Measures
NameTimeMethod
Degree of Repigmentation <br/ ><br>Complications at the site of surgeryTimepoint: 4 week <br/ ><br>8 week <br/ ><br>16 Week
© Copyright 2025. All Rights Reserved by MedPath